155
Views
12
CrossRef citations to date
0
Altmetric
Review

Amlodipine and valsartan as components of a rational and effective fixed-dose combination

&
Pages 165-174 | Published online: 27 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

E Van der Merwe & A Carboni. (2011) Strategies to improve blood pressure control and cardiovascular outcomes in hypertensive patients. South African Family Practice 53:6, pages 525-532.
Read now
Augustine N. Odili, Tom Richart, Lutgarde Thijs, Samuel Kingue, Hilaire J. Boombhi, Daniel Lemogoum, Joseph Kaptue, Marius K. Kamdem, Jean-Bruno Mipinda, Babatunde A. Omotoso, Philip M. Kolo, Ademola Aderibigbe, Ifeoma I. Ulasi, Benedict C. Anisiuba, Chinwuba K. Ijoma, Serigne A. Ba, Mouhamadou B. Ndiaye, Jan A. Staessen & Jean-René M'Buyamba-Kabangu. (2011) Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial. Blood Pressure 20:5, pages 256-266.
Read now

Articles from other publishers (10)

Giuliano Tocci & Massimo Volpe. 2015. Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Pathophysiology and Pharmacotherapy of Cardiovascular Disease 887 902 .
A. Lawrence Gould, S. Unniachan & D. Wu. (2014) Indirect treatment comparison between fixed-dose-combinations of amlodipine/losartan and amlodipine/valsartan in blood pressure control. International Journal of Clinical Practice 68:2, pages 163-172.
Crossref
Xinhuan Wan, Panqin Ma & Xiangrong Zhang. (2014) A promising choice in hypertension treatment: Fixed-dose combinations. Asian Journal of Pharmaceutical Sciences 9:1, pages 1-7.
Crossref
V. S Zadionchenko, G. G Shehyan & A. A Yalymov. (2013) Clinical use of the III generation calcium antagonist Amlotopin the treatment of patients with cardiovascular disease. CardioSomatics 4:4, pages 25-32.
Crossref
Keith C. Ferdinand & Samar A. Nasser. (2013) A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension. American Journal of Cardiovascular Drugs 13:5, pages 301-313.
Crossref
Dingliang Zhu, Kan Yang, Ningling Sun, Pingjin Gao, Ruonan Wang, Amie Grosso & Ying Zhang. (2013) Amlodipine/valsartan 5/160mg versus valsartan 160mg in Chinese hypertensives. International Journal of Cardiology 167:5, pages 2024-2030.
Crossref
Wen Shang, Ping Han, Cheng-bing Yang, Xiao-wen Gu, Wei Zhang, Li-ping Xu, Shou-ting Fu, Ding-feng Su & He-hui Xie. (2011) Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats. Acta Pharmacologica Sinica 32:9, pages 1109-1115.
Crossref
Pedro Marques da Silva. (2010) Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with Hypertension. Clinical Drug Investigation 30:9, pages 625-641.
Crossref
Julián Segura de La Morena, José Antonio García Donaire & Luis Miguel Ruilope Urioste. (2010) Nuevas estrategias terapéuticas para mejorar el control de la hipertensión arterial y simplificar la pauta de tratamiento farmacológico. Medicina Clínica 134:14, pages 635-642.
Crossref
James E. Frampton & Lesley J. Scott. (2009) Amlodipine/Valsartan Single-Pill Combination. American Journal Cardiovascular Drugs 9:5, pages 309-330.
Crossref